Literature DB >> 17490822

Dendritic distributions of dopamine D1 receptors in the rat nucleus accumbens are synergistically affected by startle-evoking auditory stimulation and apomorphine.

Y Hara1, V M Pickel.   

Abstract

Prepulse inhibition of the startle response to auditory stimulation (AS) is a measure of sensorimotor gating that is disrupted by the dopamine D1/D2 receptor agonist, apomorphine. The apomorphine effect on prepulse inhibition is ascribed in part to altered synaptic transmission in the limbic-associated shell and motor-associated core subregions of the nucleus accumbens (Acb). We used electron microscopic immunolabeling of dopamine D1 receptors (D1Rs) in the Acb shell and core to test the hypothesis that region-specific redistribution of D1Rs is a short-term consequence of AS and/or apomorphine administration. Thus, comparisons were made in the Acb of rats killed 1 h after receiving a single s.c. injection of vehicle (VEH) or apomorphine (APO) alone or in combination with startle-evoking AS (VEH+AS, APO+AS). In both regions of all animals, the D1R immunoreactivity was present in somata and large, as well as small, presumably more distal dendrites and dendritic spines. In the Acb shell, compared with the VEH+AS group, the APO+AS group had more spines containing D1R immunogold particles, and these particles were more prevalent on the plasma membranes. This suggests movement of D1Rs from distal dendrites to the plasma membrane of dendritic spines. Small- and medium-sized dendrites also showed a higher plasmalemmal density of D1R in the Acb shell of the APO+AS group compared with the APO group. In the Acb core, the APO+AS group had a higher plasmalemmal density of D1R in medium-sized dendrites compared with the APO or VEH+AS group. Also in the Acb core, D1R-labeled dendrites were significantly smaller in the VEH+AS group compared with all other groups. These results suggest that alerting stimuli and apomorphine synergistically affect distributions of D1R in Acb shell and core. Thus adaptations in D1R distribution may contribute to sensorimotor gating deficits that can be induced acutely by apomorphine or develop over time in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17490822      PMCID: PMC1978178          DOI: 10.1016/j.neuroscience.2007.04.005

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  72 in total

Review 1.  Convergence and segregation of ventral striatal inputs and outputs.

Authors:  H J Groenewegen; C I Wright; A V Beijer; P Voorn
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

Review 2.  The synaptic framework for chemical signaling in nucleus accumbens.

Authors:  G E Meredith
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

3.  ACOUSTIC VARIABLES IN THE MODIFICATION OF STARTLE REACTION IN THE RAT.

Authors:  H S HOFFMAN; J L SEARLE
Journal:  J Comp Physiol Psychol       Date:  1965-08

4.  The effects of temporary inactivation of the core and the shell subregions of the nucleus accumbens on prepulse inhibition of the acoustic startle reflex and activity in rats.

Authors:  Helen H J Pothuizen; Ana L Jongen-Rêlo; Joram Feldon
Journal:  Neuropsychopharmacology       Date:  2005-04       Impact factor: 7.853

Review 5.  Importance of animal models in schizophrenia research.

Authors:  M van den Buuse; B Garner; A Gogos; S Kusljic
Journal:  Aust N Z J Psychiatry       Date:  2005-07       Impact factor: 5.744

6.  Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine.

Authors:  T E Robinson; B Kolb
Journal:  Eur J Neurosci       Date:  1999-05       Impact factor: 3.386

7.  Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity.

Authors:  G G Kinney; L O Wilkinson; K L Saywell; M D Tricklebank
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

8.  Increased AMPA GluR1 receptor subunit labeling on the plasma membrane of dendrites in the basolateral amygdala of rats self-administering morphine.

Authors:  Michael J Glass; Paul J Kruzich; Eric E O Colago; Mary Jeanne Kreek; Virginia M Pickel
Journal:  Synapse       Date:  2005-10       Impact factor: 2.562

9.  Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats.

Authors:  V P Bakshi; M Tricklebank; H C Neijt; V Lehmann-Masten; M A Geyer
Journal:  J Pharmacol Exp Ther       Date:  1999-02       Impact factor: 4.030

10.  The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

View more
  11 in total

1.  Enhanced dendritic availability of μ-opioid receptors in inhibitory neurons of the extended amygdala in mice deficient in the corticotropin-releasing factor-1 receptor.

Authors:  Azra Jaferi; Ping Zhou; Virginia M Pickel
Journal:  Synapse       Date:  2011-01       Impact factor: 2.562

2.  Quantification of D1 and D5 dopamine receptor localization in layers I, III, and V of Macaca mulatta prefrontal cortical area 9: coexpression in dendritic spines and axon terminals.

Authors:  Jill R Bordelon-Glausier; Zafar U Khan; E Chris Muly
Journal:  J Comp Neurol       Date:  2008-06-20       Impact factor: 3.215

3.  Preferential relocation of the N-methyl-D-aspartate receptor NR1 subunit in nucleus accumbens neurons that contain dopamine D1 receptors in rats showing an apomorphine-induced sensorimotor gating deficit.

Authors:  Y Hara; V M Pickel
Journal:  Neuroscience       Date:  2008-04-12       Impact factor: 3.590

4.  Chronic desipramine treatment alters tyrosine hydroxylase but not norepinephrine transporter immunoreactivity in norepinephrine axons in the rat prefrontal cortex.

Authors:  Susan L Erickson; Anjalika R Gandhi; Josephine K Asafu-Adjei; Allan R Sampson; LeeAnn Miner; Randy D Blakely; Susan R Sesack
Journal:  Int J Neuropsychopharmacol       Date:  2011-01-06       Impact factor: 5.176

5.  Hormonal regulation of delta opioid receptor immunoreactivity in interneurons and pyramidal cells in the rat hippocampus.

Authors:  Tanya J Williams; Annelyn Torres-Reveron; Jeanette D Chapleau; Teresa A Milner
Journal:  Neurobiol Learn Mem       Date:  2011-01-09       Impact factor: 2.877

6.  Inhibition of p75 neurotrophin receptor attenuates isoflurane-mediated neuronal apoptosis in the neonatal central nervous system.

Authors:  Brian P Head; Hemal H Patel; Ingrid R Niesman; John C Drummond; David M Roth; Piyush M Patel
Journal:  Anesthesiology       Date:  2009-04       Impact factor: 7.892

7.  Deletion of the NMDA-NR1 receptor subunit gene in the mouse nucleus accumbens attenuates apomorphine-induced dopamine D1 receptor trafficking and acoustic startle behavior.

Authors:  Michael J Glass; Danielle C Robinson; Elizabeth Waters; Virginia M Pickel
Journal:  Synapse       Date:  2013-03-05       Impact factor: 2.562

8.  Subcellular plasticity of the corticotropin-releasing factor receptor in dendrites of the mouse bed nucleus of the stria terminalis following chronic opiate exposure.

Authors:  A Jaferi; D A Lane; V M Pickel
Journal:  Neuroscience       Date:  2009-06-17       Impact factor: 3.590

9.  The neurokinin-3 (NK3) and the neurokinin-1 (NK1) receptors are differentially targeted to mesocortical and mesolimbic projection neurons and to neuronal nuclei in the rat ventral tegmental area.

Authors:  Andrée Lessard; Martin Savard; Fernand Gobeil; Joseph P Pierce; Virginia M Pickel
Journal:  Synapse       Date:  2009-06       Impact factor: 2.562

10.  Cocaine withdrawal-induced trafficking of delta-opioid receptors in rat nucleus accumbens.

Authors:  Lisa M Ambrose-Lanci; Niluk B Peiris; Ellen M Unterwald; Elisabeth J Van Bockstaele
Journal:  Brain Res       Date:  2008-03-15       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.